BIO Investor Forum 2013 Speakers

  • Recommend
  • Tweet
  • Print
  • Email

Below is a list of the 2013 BIO Investor Forum speakers. To view or download the full program schedule, please click here.

For questions about programming, please contact Sondra Behan, Manager, Industry research and Programs, Business Development, Biotechnology Industry Organization at: sbehan@bio.org.

 

Photo Name and Title Panel, Date, Time Location
Srini Akkaraju, MD, PhD
General Partner
Sofinnova Ventures
Early Stage Venture Financing – Will Current Trends Continue into 2014?
Wednesday, October 9, 2013
3:30 p.m. - 4:25 p.m.
Sunset Court
Marianne Andreach
VP of Strategic Marketing & Product Planning
Esperion Therapeutics
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care
Wednesday, October 9, 2013
9:00 a.m. - 9:55 a.m.
Twin Peaks North/South
Brian Atwood
Managing Director
Versant Ventures
Early Stage Venture Financing – Will Current Trends Continue into 2014?
Wednesday, October 9, 2013
3:30 p.m. - 4:25 p.m.
Sunset Court
Jeffrey A. Baumel
Partner
Dentons
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective
Wednesday, October 9th
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
Alexis Borisy
Partner
Third Rock Ventures
Early Stage Venture Financing – Will Current Trends Continue into 2014?
Wednesday, October 9, 2013
3:30 p.m. - 4:25 p.m.
Sunset Court
James B. Breitmeyer, MD, PhD
Executive Vice President, Division President Cancer Vaccines 
Bavarian Nordic A/S
The Ultimate Rejection: Fighting Cancer with Immunotherapy
Tuesday, October 8, 2013
10:30 a.m. - 11:25 a.m.
Twin Peaks North/South
Mark Charest
Vice President
New Leaf Venture Partners
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective
Tuesday, October 8, 2013
12:00 p.m. - 1:25 p.m.
Sunset Court
Margarita Chavez
Director
AbbVie Biotech Ventures
Early Stage Venture Financing – Will Current Trends Continue into 2014?
Wednesday, October 9, 2013
3:30 p.m. - 4:25 p.m.
Sunset Court
Steve Conafay, JD
Principal
The Conafay Group
GAINing Ground in Antibiotics– New Incentives for Biopharma
Tuesday, October 8, 2013
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
Ashley Dombkowski, PhD
Managing Director
Bay City Capital
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective
Tuesday, October 8, 2013
12:00 p.m. - 1:25 p.m.
Sunset Court
Michael Dybbs, PhD
Principal
New Leaf Venture Partners
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective
Wednesday, October 9th
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
David Donabedian
Vice President, Venture Investments
AbbVie Biotech Ventures
Early Stage Venture Financing – Will Current Trends Continue into 2014?
Wednesday, October 9, 2013
3:30 p.m. - 4:25 p.m.
Sunset Court
Charles C. Duncan, PhD
Managing Director & Senior Research Analyst
Piper Jaffray
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care
Wednesday, October 9, 2013
9:00 a.m. - 9:55 a.m.
Twin Peaks North/South
Michael J. Eichberg, PhD
Senior Director, Alliance Management
Achaogen
GAINing Ground in Antibiotics– New Incentives for Biopharma
Tuesday, October 8, 2013
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
Dr. E. Cartier Esham
Acting Executive Vice President Emerging Companies, Health and Regulatory Affairs
Biotechnology Industry Organization
GAINing Ground in Antibiotics– New Incentives for Biopharma
Tuesday, October 8, 2013
2:00 p.m. - 2:55 p.m.
 
Twin Peaks North/South
Laurent Fischer, MD
Chairman and CEO
Jennerex Biotherapeutics
The Ultimate Rejection: Fighting Cancer with Immunotherapy
Tuesday, October 8, 2013
10:30 a.m. - 11:25 a.m.
Twin Peaks North/South
Simone Fishburn, PhD
Senior Editor
BioCentury Publications
Fireside Chat
October 9, 2013
10:30 a.m. - 11:30 a.m.
Twin Peaks North/South
Lawrence Fong, MD
Associate Professor, Department of Medicine (Hematology/Oncology)
UCSF Medical Center
The Ultimate Rejection: Fighting Cancer with Immunotherapy
Tuesday, October 8, 2013
10:30 a.m. - 11:25 a.m.
Twin Peaks North/South
Nicholas Franano, MD
Founder, President & CEO
Novita Therapeutics
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"?
Tuesday, October 8, 2013
3:30 p.m. - 4:25 p.m.
Twin Peaks North/South
Paul J. Hastings
President and CEO
OncoMed Pharmaceuticals
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective
Wednesday, October 9th
2:00 p.m. - 2:55 p.m.
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary
Wednesday, October 9, 2013
12:30 p.m. - 1:25 p.m
Twin Peaks North/South
James I. Healy, MD, PhD
General Partner
Sofinnova Ventures
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary
Wednesday, October 9, 2013
12:30 p.m. - 1:25 p.m
Sunset Court
Sharon Hesterlee, PhD
Vice President Research
Parent Project Muscular Dystrophy
A Guide to Effective Patient Foundation and Life Science Industry Collaborations
Tuesday, October 8, 2013
9:00 a.m. - 9:55 a.m.
Twin Peaks North/South
Paul G. Higham
CEO
immatics biotechnologies GmbH
The Ultimate Rejection: Fighting Cancer with Immunotherapy
Tuesday, October 8, 2013
10:30 a.m. - 11:25 a.m.
Twin Peaks North/South
Thomas E. Hughes, PhD
President & CEO
Zafgen
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary
Wednesday, October 9, 2013
12:30 p.m. - 1:25 p.m
Sunset Court
Thomas Kapsner
CEO
Morphochem AG
GAINing Ground in Antibiotics– New Incentives for Biopharma
Tuesday, October 8, 2013
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
J. Joseph Kim
President, Chief Executive Officer, Director
Inovio Pharmaceuticals
 
The Ultimate Rejection: Fighting Cancer with Immunotherapy
Tuesday, October 8, 2013
10:30 a.m. - 11:25 a.m.
Twin Peaks North/South
Michael Kelly, PhD
Chief Scientific Officer
CureDuchenne
A Guide to Effective Patient Foundation and Life Science Industry Collaborations
Tuesday, October 8, 2013
9:00 a.m. - 9:55 a.m.
Twin Peaks North/South
Jan M. Lundberg, Ph.D
Eli Lilly Executive Vice President, Science and Technology President
Lilly Research Laboratories
Fireside Chat
October 9, 2013
10:30 a.m. - 11:30 a.m.
Twin Peaks North/South
Gail Maderis
President & CEO
BayBio
A Guide to Effective Patient Foundation and Life Science Industry Collaborations
Tuesday, October 8, 2013
9:00 a.m. - 9:55 a.m.
 
Twin Peaks North/South
Michael Margolis, RPh
Managing Director
ROTH Capital Partners
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective
Wednesday, October 9th
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
Ed Mathers
Partner
New Enterprise Associates
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care
Wednesday, October 9, 2013
9:00 a.m. - 9:55 a.m.
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary
Wednesday, October 9, 2013
12:30 p.m. - 1:25 p.m
Twin Peaks North/South
Erin McCallister
Senior Editor
BioCentury Publications
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary
Wednesday, October 9, 2013
12:30 p.m. - 1:25 p.m
Sunset Court
Evan McCulloch, CFA
Portfolio Manager
Franklin Templeton Investments
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective
Tuesday, October 8, 2013
12:00 p.m. - 1:25 p.m.
Sunset Court
Steven J Mento, PhD
President and CEO
Conatus Pharmaceuticals
The New Road to IPO in the Age of the JOBS ACT: The Company Perspective
Wednesday, October 9th
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
Andrew Merickel, PhD
Partner
Knobbe Martens
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"?
Tuesday, October 8, 2013
3:30 p.m. - 4:25 p.m.
Twin Peaks North/South
Deepa Pakianathan, PhD
General Partner
Delphi Ventures
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"?
Tuesday, October 8, 2013
3:30 p.m. - 4:25 p.m.
Twin Peaks North/South
Joseph Pantginis, PhD
Senior Research Analyst
ROTH Capital Partners
The Ultimate Rejection: Fighting Cancer with Immunotherapy
Tuesday, October 8, 2013
10:30 a.m. - 11:25 a.m.
Twin Peaks North/South
Hemai Parthasarathy, Ph.D.
Scientific Director
Breakout Labs/Thiel Foundation
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"?
Tuesday, October 8, 2013
3:30 p.m. - 4:25 p.m.
Twin Peaks North/South
Eugene Rozelman
Managing Director
Biopharma Investment Banking, Canaccord Genuity
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective
Tuesday, October 8, 2013
12:00 p.m. - 1:25 p.m.
Sunset Court
Susan Schaeffer
Editor
BioCentury Publications
Facing Reality: Debating the Conclusions of BioCentury's 21st Annual Back to School Commentary
Wednesday, October 9, 2013
12:30 p.m. - 1:25 p.m
 
Sunset Court
Andrew J. Schwab
Managing Partner
AM Ventures
Early Stage Venture Financing – Will Current Trends Continue into 2014?
Wednesday, October 9, 2013
3:30 p.m. - 4:25 p.m.
Sunset Court
Brad Spellberg, MD
Investigator
LA BioMed
GAINing Ground in Antibiotics– New Incentives for Biopharma
Tuesday, October 8, 2013
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
Gregory C. Simon
CEO
Poliwogg
Crowdfunding in Healthcare and Biotech - Will it Bridge the "Valley of Death"?
Tuesday, October 8, 2013
3:30 p.m. - 4:25 p.m.
Twin Peaks North/South
Eugene Sun, MD
Executive Vice President, Research & Development
Rib-X Pharmaceuticals
GAINing Ground in Antibiotics– New Incentives for Biopharma
Tuesday, October 8, 2013
2:00 p.m. - 2:55 p.m.
Twin Peaks North/South
David Thomas, CFA
Director, Industry Research & Analysis
BIO
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective
Tuesday, October 8, 2013
12:00 p.m. - 1:25 p.m.
Sunset Court
Luke Timmerman
Vice President, Life Sciences Initiatives
Xconomy
 
Early Stage Venture Financing – Will Current Trends Continue into 2014?
Wednesday, October 9, 2013
3:30 p.m. - 4:25 p.m.
Sunset Court
Effie Toshav
Partner
Fenwick & West LLP
IPO Frenzy – Are the GoGo Markets Here to Stay? The Investor Perspective
Tuesday, October 8, 2013
12:00 p.m. - 1:25 p.m.
Sunset Court
Michael Wyzga
President & CEO
Radius Health
The Non-Orphan Panel: Shifting the Focus from Rare Diseases to Primary Care
Wednesday, October 9, 2013
9:00 a.m. - 9:55 a.m.
Twin Peaks North/South